A survey by Deloitte found that more than half of IT executives see blockchain as a potentially major disruptor in health care, with about three-quarters believing the technology could become a major driver of change in life sciences and pharma development, according to a HealthITAnalytics report.
Just shy of half (43 percent) of the 1,000-plus respondents have elevated its priority in their respective organizations, but 29 percent reportedly don’t see blockchain as necessary for continued success.
“Blockchain is at an inflection point, with momentum shifting from ‘blockchain tourism’ and exploration to the building of practical business applications,” Deloitte says.
Despite some hesitancy among a number of executives, roughly 60 percent, according to HealthITAnalytics, say their competitive edge will be at risk unless they look further into implementing blockchain technologies.
“As more organizations put their human and financial resources behind blockchain and come to better realize how it can improve their business processes and their bottom lines, we expect blockchain to gain significant traction as its cost savings, competitive advantages, and ROI benefits become more pronounced,” Deloitte says.